Generic placeholder image

Current Cardiology Reviews

Editor-in-Chief

ISSN (Print): 1573-403X
ISSN (Online): 1875-6557

Review Article

Contemporary Considerations in the Evolution of Wearable Technology for Arrhythmia Detection

Author(s): Tobin Joseph, Mahmoud Barrie, Akbar Karimi, Sharmi Haque, Innocent Ogunmwonyi and Utkarsh Ojha*

Volume 19, Issue 6, 2023

Published on: 01 September, 2023

Article ID: e110823219655 Pages: 7

DOI: 10.2174/1573403X19666230811093048

Price: $65

Abstract

Arrhythmias are an increasingly common cause of hospital admissions worldwide. Late detection of arrhythmias is associated with a significantly increased risk of cardiovascular complications. Early identification and management of life-threatening arrhythmias is paramount to reduce mortality. Wearable technologies are now widespread among the general population, providing a continuous output of healthcare data. However, this data are not routinely integrated into clinical practice. Here, we begin by outlining the current landscape in wearable technology for aiding arrhythmia detection; we then consider the clinical impact of wearable technology for both clinicians and patients; we further highlight the latest and emerging trials in wearable technology for arrhythmia detection and finally postulate the wider implications of the expansion of such cardiac devices.

Keywords: Arrhythmia, monitoring, wearables, technology, cardiovascular complications, cardiac devices.

Graphical Abstract
[1]
Desai DS, Hajouli S. Arrhythmias.StatPearls. Treasure Island, FL: StatPearls Publishing 2022.
[2]
Khurshid S, Choi SH, Weng LC, et al. Frequency of cardiac rhythm abnormalities in a half million adults. Circ Arrhythm Electrophysiol 2018; 11(7): e006273.
[http://dx.doi.org/10.1161/CIRCEP.118.006273] [PMID: 29954742]
[3]
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2021; 42(5): 373-498.
[http://dx.doi.org/10.1093/eurheartj/ehaa612] [PMID: 32860505]
[4]
Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J 2020; 41(5): 655-720.
[http://dx.doi.org/10.1093/eurheartj/ehz467] [PMID: 31504425]
[5]
Halcox JPJ, Wareham K, Cardew A, et al. Assessment of remote heart rhythm sampling using the alivecor heart monitor to screen for atrial fibrillation. Circulation 2017; 136(19): 1784-94.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.117.030583] [PMID: 28851729]
[6]
Burdett P, Lip GYH. Atrial fibrillation in the UK: Predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs. Eur Heart J Qual Care Clin Outcomes 2022; 8(2): 187-94.
[http://dx.doi.org/10.1093/ehjqcco/qcaa093] [PMID: 33346822]
[7]
Barrett PM, Komatireddy R, Haaser S, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med 2014; 127(1): 95.e11-7.
[http://dx.doi.org/10.1016/j.amjmed.2013.10.003] [PMID: 24384108]
[8]
Bisignani A, De Bonis S, Mancuso L, Ceravolo G, Bisignani G. Implantable loop recorder in clinical practice. J Arrhythm 2019; 35(1): 25-32.
[http://dx.doi.org/10.1002/joa3.12142] [PMID: 30805041]
[9]
Smith A, Perdue M, Vojnika J, Frisch DR, Pavri BB. The diagnostic yield of implantable loop recorders stratified by indication: “Real-world” use in a large academic hospital. J Interv Card Electrophysiol 2021; 61(2): 303-11.
[http://dx.doi.org/10.1007/s10840-020-00815-w] [PMID: 32621215]
[10]
Kajdič N, Zupan Mežnar A, Šinkovec M, Žižek D. Diagnostic yield of implantable loop recorders in patients with unexplained syncope: single-center experience. Minerva Cardiol Angiol 2021; 69(4): 419-25.
[http://dx.doi.org/10.23736/S2724-5683.20.05247-0] [PMID: 32989968]
[11]
Davis S, Westby M, Pitcher D, Petkar S. Implantable loop recorders are cost-effective when used to investigate transient loss of consciousness which is either suspected to be arrhythmic or remains unexplained. Europace 2012; 14(3): 402-9.
[http://dx.doi.org/10.1093/europace/eur343] [PMID: 22071383]
[12]
Rinciog CI, Sawyer LM, Diamantopoulos A, et al. Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the UK. Open Heart 2019; 6(1): e001037.
[http://dx.doi.org/10.1136/openhrt-2019-001037] [PMID: 31297227]
[13]
Svendsen JH, Diederichsen SZ, Højberg S, et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): A randomised controlled trial. Lancet 2021; 398(10310): 1507-16.
[http://dx.doi.org/10.1016/S0140-6736(21)01698-6] [PMID: 34469766]
[14]
Adasuriya G, Haldar S. Remote monitoring of cardiac arrhythmias using wearable digital technology: Paradigm shift or pipe dream? Eur J Arrhythm Electrophysiol 2022; 8(1): 7-12.
[http://dx.doi.org/10.17925/EJAE.2022.8.1.7]
[15]
Laricchia F. Number of connected wearable devices worldwide from 2019 to 2022. 2022. Available from : https://www.statista.com/statistics/487291/global-connected-wearable-devices/ [Accessed on: Aug. 27, 2022].
[16]
Levine DM, Lipsitz SR, Linder JA. Trends in seniors’ use of digital health technology in the United States, 2011-2014. JAMA 2016; 316(5): 538-40.
[http://dx.doi.org/10.1001/jama.2016.9124] [PMID: 27483069]
[17]
Ding EY, Marcus GM, McManus DD. Emerging technologies for identifying atrial fibrillation. Circ Res 2020; 127(1): 128-42.
[http://dx.doi.org/10.1161/CIRCRESAHA.119.316342] [PMID: 32716695]
[18]
Hampton JR. The ECG made easy. (8th ed.), Edinburgh: Churchill Livingstone/Elsevier 2013.
[19]
Pereira T, Tran N, Gadhoumi K, et al. Photoplethysmography based atrial fibrillation detection: A review. NPJ Digit Med 2020; 3(1): 3.
[http://dx.doi.org/10.1038/s41746-019-0207-9] [PMID: 31934647]
[20]
Ghamari M, Esparza A, Ghamari M, Soltanpur C, Nazeran H. A review on wearable photoplethysmography sensors and their potential future applications in health care. Int J Biosens Bioelectron 2018; 4(4): 195-202.
[http://dx.doi.org/10.15406/ijbsbe.2018.04.00125] [PMID: 30906922]
[21]
Prieto-Avalos G, Cruz-Ramos NA, Alor-Hernández G, Sánchez-Cervantes JL, Rodríguez-Mazahua L, Guarneros-Nolasco LR. Wearable devices for physical monitoring of heart: A review. Biosensors 2022; 12(5): 292.
[http://dx.doi.org/10.3390/bios12050292] [PMID: 35624593]
[22]
Seshadri DR, Bittel B, Browsky D, et al. Accuracy of apple watch for detection of atrial fibrillation. Circulation 2020; 141(8): 702-3.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044126] [PMID: 32091929]
[23]
National Institute for Health and Care Excellence Atrial fibrillation: diagnosis and management 2021. Available from:https://www.nice.org.uk/guidance/ng196 Accessed on: Aug. 27, 2022).
[24]
Overbeek DL, Hogikyan EM, Davis M, McGillicuddy DC. A unique case of bradycardia recognized by wearable technology as first presentation of complete heart block - PubMed. Am J Emerg Med 2021; 37(10): e5-1989.e7.
[25]
Walsh KA, Lin D. A smartwatch heart rate monitor prompts an unusual diagnosis. JACC Case Rep 2020; 2(3): 431-3.
[http://dx.doi.org/10.1016/j.jaccas.2019.11.087] [PMID: 34317256]
[26]
Burke J, Haigney MCP, Borne R, Krantz MJ. Smartwatch detection of ventricular tachycardia: Case series. HeartRhythm Case Rep 2020; 6(10): 800-4.
[http://dx.doi.org/10.1016/j.hrcr.2020.08.003] [PMID: 33101960]
[27]
Rizas KD, Freyer L, Sappler N, et al. Smartphone-based screening for atrial fibrillation: A pragmatic randomized clinical trial. Nat Med 2022; 28(9): 1823-30.
[http://dx.doi.org/10.1038/s41591-022-01979-w] [PMID: 36031651]
[28]
Lubitz SA, Faranesh AZ, Selvaggi C, et al. Detection of atrial fibrillation in a large population using wearable devices: The fitbit heart study. Circulation 2022; 146(19): 1415-24.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.122.060291] [PMID: 36148649]
[29]
Bayoumy K, Gaber M, Elshafeey A, et al. Smart wearable devices in cardiovascular care: Where we are and how to move forward. Nat Rev Cardiol 2021; 18(8): 581-99.
[http://dx.doi.org/10.1038/s41569-021-00522-7] [PMID: 33664502]
[30]
Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: Use the right tool for the right outcome, in the right population. Europace 2020; 22(8): 1147-8.
[http://dx.doi.org/10.1093/europace/euaa065] [PMID: 32538434]
[31]
ClinicalTrialsgov A Study of the Acceptability and Performance of Wearables for Atrial Fibrillation Screening in Older Adults Bethesda (MD). US: National Library of Medicine 2021.
[32]
ClinicalTrials.gov Remote Monitoring of AF Recurrence Using mHealth Technology 2021.
[33]
ClincalTrials.gov. A Study to Investigate if Early Atrial Fibrillation (AF) Diagnosis Reduces Risk of Events Like Stroke in the RealWorld.
[34]
ClinicalTrials.gov Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation.
[35]
Wang L, Nielsen K, Goldberg J, et al. Association of wearable device use with pulse rate and health care use in adults with atrial fibrillation. JAMA Netw Open 2021; 4(5): e215821.
[http://dx.doi.org/10.1001/jamanetworkopen.2021.5821] [PMID: 34042996]
[36]
Ferguson C, Hickman LD, Turkmani S, Breen P, Gargiulo G, Inglis SC. “Wearables only work on patients that wear them”: Barriers and facilitators to the adoption of wearable cardiac monitoring technologies. Cardiovasc Digit Health J 2021; 2(2): 137-47.
[http://dx.doi.org/10.1016/j.cvdhj.2021.02.001] [PMID: 35265900]
[37]
Smuck M, Odonkor CA, Wilt JK, Schmidt N, Swiernik MA. The emerging clinical role of wearables: factors for successful implementation in healthcare. NPJ Digit Med 2021; 4(1): 45.
[http://dx.doi.org/10.1038/s41746-021-00418-3] [PMID: 33692479]
[38]
Predel C, Steger F. Ethical challenges with smartwatch-based screening for atrial fibrillation: Putting users at risk for marketing purposes? Front Cardiovasc Med 2021; 7: 615927.
[http://dx.doi.org/10.3389/fcvm.2020.615927] [PMID: 33521064]
[39]
Assessing fitness to drive: A guide for medical professionals. Driver and Vehicle Licensing Agency 2022.
[40]
Guest AJ, Chen YL, Pearson N, King JA, Paine NJ, Clemes SA. Cardiometabolic risk factors and mental health status among truck drivers: A systematic review. BMJ Open 2020; 10(10): e038993.
[http://dx.doi.org/10.1136/bmjopen-2020-038993] [PMID: 33099498]
[41]
Wearable Technology Market Size, Trends, Growth, Report 2030 Precedence Research. 2022. Available from: https://www.precedenceresearch.com/wearable-technology-market [Accessed on: Jun. 26, 2023].
[42]
Baranchuk A, Refaat MM, Patton KK, et al. Cybersecurity for cardiac implantable electronic devices. J Am Coll Cardiol 2018; 71(11): 1284-8.
[http://dx.doi.org/10.1016/j.jacc.2018.01.023] [PMID: 29475627]
[43]
MW is Short St Jude Medical (STJ:US) - Muddy Waters Research. 2016. Available from: https://www.muddywatersresearch.com/research/stj/mw-is-short-stj/ Accessed on: Jun. 26, 2023].
[44]
Tran VT, Riveros C, Ravaud P. Patients’ views of wearable devices and AI in healthcare: Findings from the ComPaRe e-cohort. NPJ Digit Med 2019; 2(1): 53.
[http://dx.doi.org/10.1038/s41746-019-0132-y] [PMID: 31304399]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy